BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1290479 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)C(CNC(=O)OC(C)(C)C)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C50H58FN3O11/c1-29-21-39-38-14-12-34-23-36(55)17-19-47(34,5)49(38,51)40(56)24-48(39,6)50(29,62)41(57)28-64-43(59)16-15-42(58)63-27-30-7-9-31(10-8-30)37(26-53-45(61)65-46(2,3)4)44(60)54-35-13-11-33-25-52-20-18-32(33)22-35/h7-11,13,17-20,22-23,25,29,37-40,56,62H,12,14-16,21,24,26-28H2,1-6H3,(H,53,61)(H,54,60) UEQBOLNXUTWGTF-UHFFFAOYSA-N 511466 US11059789, Example 4::US11691950, Example 4 Tumor necrosis factor Homo sapiens 230 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511466 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511466&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436330 459628724 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1290480 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)C(CCNC(=O)OC(C)(C)C)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C51H60FN3O11/c1-30-23-40-39-14-12-35-25-37(56)17-20-48(35,5)50(39,52)41(57)26-49(40,6)51(30,63)42(58)29-65-44(60)16-15-43(59)64-28-31-7-9-32(10-8-31)38(19-22-54-46(62)66-47(2,3)4)45(61)55-36-13-11-34-27-53-21-18-33(34)24-36/h7-11,13,17-18,20-21,24-25,27,30,38-41,57,63H,12,14-16,19,22-23,26,28-29H2,1-6H3,(H,54,62)(H,55,61) MSIJHDSLZXTECH-UHFFFAOYSA-N 511467 US11059789, Example 11::US11691950, Example 11 Tumor necrosis factor Homo sapiens 429 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511467 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511467&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146440332 459628725 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1290481 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)C(CCN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H52FN3O9/c1-27-20-37-36-11-9-32-22-34(51)14-17-43(32,2)45(36,47)38(52)23-44(37,3)46(27,57)39(53)26-59-41(55)13-12-40(54)58-25-28-4-6-29(7-5-28)35(15-18-48)42(56)50-33-10-8-31-24-49-19-16-30(31)21-33/h4-8,10,14,16-17,19,21-22,24,27,35-38,52,57H,9,11-13,15,18,20,23,25-26,48H2,1-3H3,(H,50,56) GUTVQHWPCMVMML-UHFFFAOYSA-N 511468 US11059789, Example 12::US11691950, Example 12 Tumor necrosis factor Homo sapiens 90.5 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511468 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511468&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436258 459628726 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1290482 CC(C)(C)OC(=O)NC[C@@H](C(=O)Nc1ccc2cnccc2c1)c1ccc(COC(=O)CCC(=O)OCC(=O)[C@@]2(O)CC[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)cc1 |r,c:53,t:49| InChI=1S/C49H57N3O11/c1-46(2,3)63-45(59)51-26-37(44(58)52-34-12-10-32-25-50-21-18-31(32)22-34)30-8-6-29(7-9-30)27-61-41(56)14-15-42(57)62-28-40(55)49(60)20-17-38-36-13-11-33-23-35(53)16-19-47(33,4)43(36)39(54)24-48(38,49)5/h6-10,12,16,18-19,21-23,25,36-39,43,54,60H,11,13-15,17,20,24,26-28H2,1-5H3,(H,51,59)(H,52,58) RJKPJPWVZSJWGK-UHFFFAOYSA-N 511469 US11059789, Example 14::US11691950, Example 14 Tumor necrosis factor Homo sapiens 620 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511469 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511469&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436145 459628727 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1290483 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1cccc(c1)[C@@H]1C[C@H]1C(=O)Nc1ccc2cnccc2c1F |r,c:11,t:7| InChI=1S/C42H42F2N2O7/c1-22-15-32-31-9-8-26-17-27(47)11-13-39(26,2)41(31,44)34(48)19-40(32,3)42(22,52)35(49)21-53-38(51)24-6-4-5-23(16-24)29-18-30(29)37(50)46-33-10-7-25-20-45-14-12-28(25)36(33)43/h4-7,10-14,16-17,20,22,29-32,34,48,52H,8-9,15,18-19,21H2,1-3H3,(H,46,50) RWLVGLOMZNKUNE-UHFFFAOYSA-N 511470 US11059789, Example 91::US11691950, Example 91 Tumor necrosis factor Homo sapiens 102 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511470 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511470&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 160748218 459628728 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1290484 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1cccc(c1)[C@@H]1C[C@H]1C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C42H43FN2O7/c1-23-15-34-33-10-8-28-18-30(46)11-13-39(28,2)41(33,43)35(47)20-40(34,3)42(23,51)36(48)22-52-38(50)26-6-4-5-25(16-26)31-19-32(31)37(49)45-29-9-7-27-21-44-14-12-24(27)17-29/h4-7,9,11-14,16-18,21,23,31-35,47,51H,8,10,15,19-20,22H2,1-3H3,(H,45,49) NJWSVCPJWIGNCK-UHFFFAOYSA-N 511471 US11059789, Example 90::US11691950, Example 90 Tumor necrosis factor Homo sapiens 300 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511471 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511471&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146423357 459628729 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1290485 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)C(N(C)C)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H52FN3O9/c1-27-20-36-35-13-11-32-22-34(51)16-18-43(32,2)45(35,47)37(52)23-44(36,3)46(27,57)38(53)26-59-40(55)15-14-39(54)58-25-28-6-8-29(9-7-28)41(50(4)5)42(56)49-33-12-10-31-24-48-19-17-30(31)21-33/h6-10,12,16-19,21-22,24,27,35-37,41,52,57H,11,13-15,20,23,25-26H2,1-5H3,(H,49,56) FPOMHYBUZWXMID-UHFFFAOYSA-N 511472 US11059789, Example 20::US11691950, Example 20 Tumor necrosis factor Homo sapiens 144 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511472 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511472&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436251 459628730 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1290486 CN(C)C(C(=O)Nc1ccc2cnccc2c1)c1ccc(COC(=O)CCC(=O)OCC(=O)[C@@]2(O)CC[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)cc1 |r,c:47,t:43| InChI=1S/C45H51N3O9/c1-43-18-15-33(49)22-31(43)10-12-34-35-16-19-45(55,44(35,2)23-36(50)40(34)43)37(51)26-57-39(53)14-13-38(52)56-25-27-5-7-28(8-6-27)41(48(3)4)42(54)47-32-11-9-30-24-46-20-17-29(30)21-32/h5-9,11,15,17-18,20-22,24,34-36,40-41,50,55H,10,12-14,16,19,23,25-26H2,1-4H3,(H,47,54) HKKMDATZSXPGQM-UHFFFAOYSA-N 511473 US11059789, Example 21::US11691950, Example 21 Tumor necrosis factor Homo sapiens 1650 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511473 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511473&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436178 459628731 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1290487 CN(C)C(C(=O)Nc1ccc2cnccc2c1)c1ccc(COC(=O)CCC(=O)OCC(=O)[C@@]23OC(C)(C)O[C@@H]2C[C@H]2[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]32C)cc1 |r,c:53,t:49| InChI=1S/C48H53F2N3O10/c1-44(2)62-39-22-33-34-21-36(49)35-20-32(54)15-17-45(35,3)47(34,50)37(55)23-46(33,4)48(39,63-44)38(56)26-61-41(58)14-13-40(57)60-25-27-7-9-28(10-8-27)42(53(5)6)43(59)52-31-12-11-30-24-51-18-16-29(30)19-31/h7-12,15-20,24,33-34,36-37,39,42,55H,13-14,21-23,25-26H2,1-6H3,(H,52,59) UDLFKDHOQVRFSO-UHFFFAOYSA-N 511474 US11059789, Example 23::US11691950, Example 23 Tumor necrosis factor Homo sapiens 4.50 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511474 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511474&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436152 459628732 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1290488 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCCc1ccc(cc1)C(CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H52FN3O9/c1-27-20-37-36-11-9-32-22-34(51)14-17-43(32,2)45(36,47)38(52)23-44(37,3)46(27,57)39(53)26-59-41(55)13-12-40(54)58-19-16-28-4-6-29(7-5-28)35(24-48)42(56)50-33-10-8-31-25-49-18-15-30(31)21-33/h4-8,10,14-15,17-18,21-22,25,27,35-38,52,57H,9,11-13,16,19-20,23-24,26,48H2,1-3H3,(H,50,56) KDXGBJLMWSDKLX-UHFFFAOYSA-N 511475 US11059789, Example 26::US11691950, Example 26 Tumor necrosis factor Homo sapiens 227 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511475 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511475&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146440333 459628733 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1290489 CN(C)C(C(=O)Nc1ccc2cnccc2c1)c1ccc(COC(=O)CCC(=O)OCC(=O)[C@@]23OC(C)(C)O[C@@H]2C[C@H]2[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]32C)cc1 |r,c:52,t:48| InChI=1S/C48H54FN3O10/c1-44(2)61-39-23-36-35-14-12-32-22-34(53)17-19-45(32,3)47(35,49)37(54)24-46(36,4)48(39,62-44)38(55)27-60-41(57)16-15-40(56)59-26-28-7-9-29(10-8-28)42(52(5)6)43(58)51-33-13-11-31-25-50-20-18-30(31)21-33/h7-11,13,17-22,25,35-37,39,42,54H,12,14-16,23-24,26-27H2,1-6H3,(H,51,58) NJXDFCQZYYGOBB-UHFFFAOYSA-N 511476 US11059789, Example 28::US11691950, Example 28 Tumor necrosis factor Homo sapiens 15.5 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511476 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511476&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436220 459628734 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1290490 CC(C)(C)OC(=O)NC[C@@H](C(=O)Nc1ccc2cnccc2c1)c1ccc(COC(=O)CCC(=O)OCC(=O)[C@@]23OC(C)(C)O[C@@H]2C[C@H]2[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]32C)cc1 |r,c:58,t:54| InChI=1S/C52H60FN3O12/c1-47(2,3)67-46(63)55-27-37(45(62)56-35-14-12-33-26-54-21-19-32(33)22-35)31-10-8-30(9-11-31)28-64-43(60)16-17-44(61)65-29-41(59)52-42(66-48(4,5)68-52)24-39-38-15-13-34-23-36(57)18-20-49(34,6)51(38,53)40(58)25-50(39,52)7/h8-12,14,18-23,26,37-40,42,58H,13,15-17,24-25,27-29H2,1-7H3,(H,55,63)(H,56,62) OPJTYLHDVVEQCS-UHFFFAOYSA-N 511477 US11059789, Example 29::US11691950, Example 29 Tumor necrosis factor Homo sapiens 71.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511477 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511477&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436163 459628735 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1290491 CC(C)(C)OC(=O)NCC(C(=O)Nc1ccc2cnccc2c1)c1ccc(CCOC(=O)CCC(=O)OCC(=O)[C@@]23OC(C)(C)O[C@@H]2C[C@H]2[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]32C)cc1 |r,c:60,t:56| InChI=1S/C53H61F2N3O12/c1-48(2,3)69-47(65)57-28-36(46(64)58-34-13-12-33-27-56-20-17-32(33)22-34)31-10-8-30(9-11-31)18-21-66-44(62)14-15-45(63)67-29-42(61)53-43(68-49(4,5)70-53)25-37-38-24-40(54)39-23-35(59)16-19-50(39,6)52(38,55)41(60)26-51(37,53)7/h8-13,16-17,19-20,22-23,27,36-38,40-41,43,60H,14-15,18,21,24-26,28-29H2,1-7H3,(H,57,65)(H,58,64) PLVZEHZCPBAVPV-UHFFFAOYSA-N 511478 US11059789, Example 31::US11691950, Example 31 Tumor necrosis factor Homo sapiens 5465 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511478 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511478&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436319 459628736 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1290492 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCCc1ccc(cc1)C(CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C47H52FN3O9/c1-26-18-38-37-11-9-31-20-33(52)12-15-44(31,2)46(37,48)39(53)22-45(38,3)47(26,58)40(54)25-60-43(57)35-21-34(35)42(56)59-17-14-27-4-6-28(7-5-27)36(23-49)41(55)51-32-10-8-30-24-50-16-13-29(30)19-32/h4-8,10,12-13,15-16,19-20,24,26,34-39,53,58H,9,11,14,17-18,21-23,25,49H2,1-3H3,(H,51,55) CHDOSVLRPHWCQD-UHFFFAOYSA-N 511479 US11059789, Example 37::US11691950, Example 37 Tumor necrosis factor Homo sapiens 3100 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511479 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511479&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146440439 459628737 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1290493 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 Rho-associated protein kinase 2 Homo sapiens 13.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5478&target=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MSRPPPTGKMPGAPETAPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRENLLLSDSPSCRETDSIQSRKNEESQEIQKKLYTLEEHLSNEMQAKEELEQKCKSVNTRLEKTAKELEEEITLRKSVESALRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQNSQISTEKVNQLQRQLDETNALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRICGLEEDLKNGKILLAKVELEKRQLQERFTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKATKARLADKNKIYESIEEAKSEAMKEMEKKLLEERTLKQKVENLLLEAEKRCSLLDCDLKQSQQKINELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLGKELQQKKQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDVQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGNDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGLDSSSIGSGPGDAEADDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEQEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVYYDISTAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS 7P6Q,7P6P,7P6O,7P6N,7JNT,9HFP,8GDS,4WOT,7JOV,5U7Q,2H9V,2F2U,8X92,8X8Z,8X8Y,8X8X,6ED6 Rho-associated protein kinase 2 ROCK2_HUMAN O75116 Q53QZ0 Q53SJ7 Q9UQN5 1290494 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 Rho-associated protein kinase 1 Homo sapiens 19.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2734&target=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS 8ZH5,7JOU,5WNH,5WNG,5WNF,5WNE,5UZJ,5KKT,5KKS,5HVU,5BML,4YVE,4YVC,3V8S,3TWJ,3TV7,3NDM,3NCZ,3D9V,2ETR,2ETK,2ESM,6E9W,4W7P,2V55,7S26,7S25,8X92,8X8Z,8X8Y,8X8X,6ED6,3O0Z,8P0S Rho-associated protein kinase 1 ROCK1_HUMAN Q13464 B0YJ91 Q2KHM4 Q59GZ4 1290495 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens 71.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1592&target=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF 3MVJ,7Y1G,6QJ7,6C0U,5UZK,5J5X,5IZJ,5IZF,5BX7,5BX6,4UJB,4UJA,4UJ9,4UJ2,4UJ1,3VQH,3POO,3P0M,3OXT,3OWP,3OVV,3OOG,3L9L,3AGM,3AGL,9DCD,6NO7,6BYS,4WB5,4DG3,4DFY,2GNI,2GNH,2GNG,2GNF,1XH9,9O7V,9EDE,9EDD,9EDC,7V0G,7UJX,5JR7,4X6Q,4WBB,4HPU,4HPT,4DIN,4DH8,4DH7,4DH5,4DH3,4DH1,4DG2,4DG0,3TNQ,3TNP,3OW3,3O7L,3IDC,3IDB,3FJQ,2QVS,2QCS,2CPK,1REK,1REJ,1RE8,1L3R,1JLU,1J3H,1FMO,1BX6,1BKX,1ATP,6E21,4XW6,4XW5,4XW4,4IB3,4IB1,4IB0,4IAZ,4IAY,4IAK,4IAI,4IAF,4IAD,4IAC,2UZW,2UZV,2UZU,2UZT,5X3F cAMP-dependent protein kinase catalytic subunit alpha KAPCA_HUMAN P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9 1290496 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 Tyrosine-protein kinase JAK1 Homo sapiens 50000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4917&target=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 5L04,5IXI,5IXD,6SMB,6SM8,6ELR,8S85,6RSH,6RSE,6RSD,6RSC,6RSB,6N7D,6N7C,6N7B,6N7A,6N79,6N78,6N77,6HZU,5WO4,5HX8,4K77,4K6Z,4IVD,4IVC,4IVB,4I5C,4FK6,4EI4,4EHZ,4E5W,4E4N,4E4L,6GGH,6TPF,6TPE,6AAH,5E1E,3EYH,3EYG Tyrosine-protein kinase JAK1 JAK1_HUMAN P23458 Q59GQ2 Q9UD26 1290497 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 Tyrosine-protein kinase JAK2 Homo sapiens 38320 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4918&target=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 6E2Q,6E2P,4JIA,4JI9,4IVA,4HGE,6WTQ,6WTP,6WTO,6WTN,4AQC,5AEP,4D1S,4D0X,4D0W,3RVG,3TJD,3TJC,7REE,7LL4,5CF6,5CF5,5CF4,4ZIM,5CF8,3Q32,3LPB,3KRR,7LL5,6VSN,6VS3,6VNM,6VNL,6VNK,6VNJ,6VNI,6VNH,6VNG,6VNF,6VNE,6VNC,6VNB,6VN8,6VGL,6DRW,5USY,3E64,3E63,3E62,4P7E,3FUP,2B7A,3KCK,3IOK,3IO7,4YTI,4YTH,4YTF,4YTC,7UYW,3JY9,7F7W Tyrosine-protein kinase JAK2 JAK2_HUMAN O60674 O14636 O75297 1290498 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 Tyrosine-protein kinase JAK3 Homo sapiens 17730 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4919&target=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRIRFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFAQHRSDLVSGRLPVGLSLKEQGECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVRRALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGDGGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPGLPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTGGSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRPHSSLRELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQYQLSQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCMESFLEAASLMSQVSYRHLVLLHGVCMAGDSTMVQEFVHLGAIDMYLRKRGHLVPASWKLQVVKQLAYALNYLEDKGLPHGNVSARKVLLAREGADGSPPFIKLSDPGVSPAVLSLEMLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYEDRQQLPAPKWTELALLIQQCMAYEPVQRPSFRAVIRDLNSLISSDYELLSDPTPGALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 7C3N,3PJC,6DUD,6DB4,6DB3,6DA4,5TTV,5TTU,5TTS,5TOZ Tyrosine-protein kinase JAK3 JAK3_HUMAN P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2 N/A A0A024R7M7 1290499 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 Non-receptor tyrosine-protein kinase TYK2 Homo sapiens 50000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4916&target=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC 4PO6,3ZON,5C03,5C01,8TB6,8TB5,3NZ0,7UYU,7UYT,7UYS,7UYR,8S9A,8S99,8S98,7AX4 Non-receptor tyrosine-protein kinase TYK2 TYK2_HUMAN P29597 Q6QB10 Q96CH0 1290500 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 Inhibitor of nuclear factor kappa-B kinase subunit beta Homo sapiens 32886 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2933&target=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS Inhibitor of nuclear factor kappa-B kinase subunit beta IKKB_HUMAN O14920 B4DZ30 B4E0U4 O75327 1290501 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 Rho-associated protein kinase 2 Homo sapiens 17.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5478&target=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MSRPPPTGKMPGAPETAPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRENLLLSDSPSCRETDSIQSRKNEESQEIQKKLYTLEEHLSNEMQAKEELEQKCKSVNTRLEKTAKELEEEITLRKSVESALRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQNSQISTEKVNQLQRQLDETNALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRICGLEEDLKNGKILLAKVELEKRQLQERFTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKATKARLADKNKIYESIEEAKSEAMKEMEKKLLEERTLKQKVENLLLEAEKRCSLLDCDLKQSQQKINELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLGKELQQKKQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDVQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGNDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGLDSSSIGSGPGDAEADDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEQEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVYYDISTAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS 7P6Q,7P6P,7P6O,7P6N,7JNT,9HFP,8GDS,4WOT,7JOV,5U7Q,2H9V,2F2U,8X92,8X8Z,8X8Y,8X8X,6ED6 Rho-associated protein kinase 2 ROCK2_HUMAN O75116 Q53QZ0 Q53SJ7 Q9UQN5 1290502 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 Rho-associated protein kinase 1 Homo sapiens 25.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2734&target=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS 8ZH5,7JOU,5WNH,5WNG,5WNF,5WNE,5UZJ,5KKT,5KKS,5HVU,5BML,4YVE,4YVC,3V8S,3TWJ,3TV7,3NDM,3NCZ,3D9V,2ETR,2ETK,2ESM,6E9W,4W7P,2V55,7S26,7S25,8X92,8X8Z,8X8Y,8X8X,6ED6,3O0Z,8P0S Rho-associated protein kinase 1 ROCK1_HUMAN Q13464 B0YJ91 Q2KHM4 Q59GZ4 1290503 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens 138 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1592&target=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF 3MVJ,7Y1G,6QJ7,6C0U,5UZK,5J5X,5IZJ,5IZF,5BX7,5BX6,4UJB,4UJA,4UJ9,4UJ2,4UJ1,3VQH,3POO,3P0M,3OXT,3OWP,3OVV,3OOG,3L9L,3AGM,3AGL,9DCD,6NO7,6BYS,4WB5,4DG3,4DFY,2GNI,2GNH,2GNG,2GNF,1XH9,9O7V,9EDE,9EDD,9EDC,7V0G,7UJX,5JR7,4X6Q,4WBB,4HPU,4HPT,4DIN,4DH8,4DH7,4DH5,4DH3,4DH1,4DG2,4DG0,3TNQ,3TNP,3OW3,3O7L,3IDC,3IDB,3FJQ,2QVS,2QCS,2CPK,1REK,1REJ,1RE8,1L3R,1JLU,1J3H,1FMO,1BX6,1BKX,1ATP,6E21,4XW6,4XW5,4XW4,4IB3,4IB1,4IB0,4IAZ,4IAY,4IAK,4IAI,4IAF,4IAD,4IAC,2UZW,2UZV,2UZU,2UZT,5X3F cAMP-dependent protein kinase catalytic subunit alpha KAPCA_HUMAN P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9 1290504 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 Tyrosine-protein kinase JAK1 Homo sapiens 50000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4917&target=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 5L04,5IXI,5IXD,6SMB,6SM8,6ELR,8S85,6RSH,6RSE,6RSD,6RSC,6RSB,6N7D,6N7C,6N7B,6N7A,6N79,6N78,6N77,6HZU,5WO4,5HX8,4K77,4K6Z,4IVD,4IVC,4IVB,4I5C,4FK6,4EI4,4EHZ,4E5W,4E4N,4E4L,6GGH,6TPF,6TPE,6AAH,5E1E,3EYH,3EYG Tyrosine-protein kinase JAK1 JAK1_HUMAN P23458 Q59GQ2 Q9UD26 1290505 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 Tyrosine-protein kinase JAK2 Homo sapiens 40871 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4918&target=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 6E2Q,6E2P,4JIA,4JI9,4IVA,4HGE,6WTQ,6WTP,6WTO,6WTN,4AQC,5AEP,4D1S,4D0X,4D0W,3RVG,3TJD,3TJC,7REE,7LL4,5CF6,5CF5,5CF4,4ZIM,5CF8,3Q32,3LPB,3KRR,7LL5,6VSN,6VS3,6VNM,6VNL,6VNK,6VNJ,6VNI,6VNH,6VNG,6VNF,6VNE,6VNC,6VNB,6VN8,6VGL,6DRW,5USY,3E64,3E63,3E62,4P7E,3FUP,2B7A,3KCK,3IOK,3IO7,4YTI,4YTH,4YTF,4YTC,7UYW,3JY9,7F7W Tyrosine-protein kinase JAK2 JAK2_HUMAN O60674 O14636 O75297 1290506 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 Tyrosine-protein kinase JAK3 Homo sapiens 21390 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4919&target=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRIRFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFAQHRSDLVSGRLPVGLSLKEQGECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVRRALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGDGGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPGLPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTGGSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRPHSSLRELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQYQLSQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCMESFLEAASLMSQVSYRHLVLLHGVCMAGDSTMVQEFVHLGAIDMYLRKRGHLVPASWKLQVVKQLAYALNYLEDKGLPHGNVSARKVLLAREGADGSPPFIKLSDPGVSPAVLSLEMLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYEDRQQLPAPKWTELALLIQQCMAYEPVQRPSFRAVIRDLNSLISSDYELLSDPTPGALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 7C3N,3PJC,6DUD,6DB4,6DB3,6DA4,5TTV,5TTU,5TTS,5TOZ Tyrosine-protein kinase JAK3 JAK3_HUMAN P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2 N/A A0A024R7M7 1290507 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 Non-receptor tyrosine-protein kinase TYK2 Homo sapiens 50000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4916&target=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC 4PO6,3ZON,5C03,5C01,8TB6,8TB5,3NZ0,7UYU,7UYT,7UYS,7UYR,8S9A,8S99,8S98,7AX4 Non-receptor tyrosine-protein kinase TYK2 TYK2_HUMAN P29597 Q6QB10 Q96CH0 1290508 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 Inhibitor of nuclear factor kappa-B kinase subunit beta Homo sapiens 38496 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2933&target=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS Inhibitor of nuclear factor kappa-B kinase subunit beta IKKB_HUMAN O14920 B4DZ30 B4E0U4 O75327 1290509 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 Rho-associated protein kinase 2 Homo sapiens 9.00 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5478&target=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MSRPPPTGKMPGAPETAPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRENLLLSDSPSCRETDSIQSRKNEESQEIQKKLYTLEEHLSNEMQAKEELEQKCKSVNTRLEKTAKELEEEITLRKSVESALRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQNSQISTEKVNQLQRQLDETNALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRICGLEEDLKNGKILLAKVELEKRQLQERFTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKATKARLADKNKIYESIEEAKSEAMKEMEKKLLEERTLKQKVENLLLEAEKRCSLLDCDLKQSQQKINELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLGKELQQKKQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDVQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGNDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGLDSSSIGSGPGDAEADDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEQEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVYYDISTAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS 7P6Q,7P6P,7P6O,7P6N,7JNT,9HFP,8GDS,4WOT,7JOV,5U7Q,2H9V,2F2U,8X92,8X8Z,8X8Y,8X8X,6ED6 Rho-associated protein kinase 2 ROCK2_HUMAN O75116 Q53QZ0 Q53SJ7 Q9UQN5 1290510 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 Rho-associated protein kinase 1 Homo sapiens 11.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2734&target=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS 8ZH5,7JOU,5WNH,5WNG,5WNF,5WNE,5UZJ,5KKT,5KKS,5HVU,5BML,4YVE,4YVC,3V8S,3TWJ,3TV7,3NDM,3NCZ,3D9V,2ETR,2ETK,2ESM,6E9W,4W7P,2V55,7S26,7S25,8X92,8X8Z,8X8Y,8X8X,6ED6,3O0Z,8P0S Rho-associated protein kinase 1 ROCK1_HUMAN Q13464 B0YJ91 Q2KHM4 Q59GZ4 1290511 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens 29.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1592&target=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF 3MVJ,7Y1G,6QJ7,6C0U,5UZK,5J5X,5IZJ,5IZF,5BX7,5BX6,4UJB,4UJA,4UJ9,4UJ2,4UJ1,3VQH,3POO,3P0M,3OXT,3OWP,3OVV,3OOG,3L9L,3AGM,3AGL,9DCD,6NO7,6BYS,4WB5,4DG3,4DFY,2GNI,2GNH,2GNG,2GNF,1XH9,9O7V,9EDE,9EDD,9EDC,7V0G,7UJX,5JR7,4X6Q,4WBB,4HPU,4HPT,4DIN,4DH8,4DH7,4DH5,4DH3,4DH1,4DG2,4DG0,3TNQ,3TNP,3OW3,3O7L,3IDC,3IDB,3FJQ,2QVS,2QCS,2CPK,1REK,1REJ,1RE8,1L3R,1JLU,1J3H,1FMO,1BX6,1BKX,1ATP,6E21,4XW6,4XW5,4XW4,4IB3,4IB1,4IB0,4IAZ,4IAY,4IAK,4IAI,4IAF,4IAD,4IAC,2UZW,2UZV,2UZU,2UZT,5X3F cAMP-dependent protein kinase catalytic subunit alpha KAPCA_HUMAN P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9 1290512 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 Tyrosine-protein kinase JAK1 Homo sapiens 34675 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4917&target=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 5L04,5IXI,5IXD,6SMB,6SM8,6ELR,8S85,6RSH,6RSE,6RSD,6RSC,6RSB,6N7D,6N7C,6N7B,6N7A,6N79,6N78,6N77,6HZU,5WO4,5HX8,4K77,4K6Z,4IVD,4IVC,4IVB,4I5C,4FK6,4EI4,4EHZ,4E5W,4E4N,4E4L,6GGH,6TPF,6TPE,6AAH,5E1E,3EYH,3EYG Tyrosine-protein kinase JAK1 JAK1_HUMAN P23458 Q59GQ2 Q9UD26 1290513 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 Tyrosine-protein kinase JAK2 Homo sapiens 22021 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4918&target=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 6E2Q,6E2P,4JIA,4JI9,4IVA,4HGE,6WTQ,6WTP,6WTO,6WTN,4AQC,5AEP,4D1S,4D0X,4D0W,3RVG,3TJD,3TJC,7REE,7LL4,5CF6,5CF5,5CF4,4ZIM,5CF8,3Q32,3LPB,3KRR,7LL5,6VSN,6VS3,6VNM,6VNL,6VNK,6VNJ,6VNI,6VNH,6VNG,6VNF,6VNE,6VNC,6VNB,6VN8,6VGL,6DRW,5USY,3E64,3E63,3E62,4P7E,3FUP,2B7A,3KCK,3IOK,3IO7,4YTI,4YTH,4YTF,4YTC,7UYW,3JY9,7F7W Tyrosine-protein kinase JAK2 JAK2_HUMAN O60674 O14636 O75297 1290514 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 Tyrosine-protein kinase JAK3 Homo sapiens 7729 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4919&target=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRIRFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFAQHRSDLVSGRLPVGLSLKEQGECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVRRALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGDGGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPGLPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTGGSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRPHSSLRELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQYQLSQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCMESFLEAASLMSQVSYRHLVLLHGVCMAGDSTMVQEFVHLGAIDMYLRKRGHLVPASWKLQVVKQLAYALNYLEDKGLPHGNVSARKVLLAREGADGSPPFIKLSDPGVSPAVLSLEMLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYEDRQQLPAPKWTELALLIQQCMAYEPVQRPSFRAVIRDLNSLISSDYELLSDPTPGALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 7C3N,3PJC,6DUD,6DB4,6DB3,6DA4,5TTV,5TTU,5TTS,5TOZ Tyrosine-protein kinase JAK3 JAK3_HUMAN P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2 N/A A0A024R7M7 1290515 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 Non-receptor tyrosine-protein kinase TYK2 Homo sapiens 50000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4916&target=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC 4PO6,3ZON,5C03,5C01,8TB6,8TB5,3NZ0,7UYU,7UYT,7UYS,7UYR,8S9A,8S99,8S98,7AX4 Non-receptor tyrosine-protein kinase TYK2 TYK2_HUMAN P29597 Q6QB10 Q96CH0 1290516 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 Inhibitor of nuclear factor kappa-B kinase subunit beta Homo sapiens 19151 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2933&target=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS Inhibitor of nuclear factor kappa-B kinase subunit beta IKKB_HUMAN O14920 B4DZ30 B4E0U4 O75327 1290517 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 Rho-associated protein kinase 2 Homo sapiens 26.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5478&target=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MSRPPPTGKMPGAPETAPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRENLLLSDSPSCRETDSIQSRKNEESQEIQKKLYTLEEHLSNEMQAKEELEQKCKSVNTRLEKTAKELEEEITLRKSVESALRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQNSQISTEKVNQLQRQLDETNALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRICGLEEDLKNGKILLAKVELEKRQLQERFTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKATKARLADKNKIYESIEEAKSEAMKEMEKKLLEERTLKQKVENLLLEAEKRCSLLDCDLKQSQQKINELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLGKELQQKKQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDVQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGNDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGLDSSSIGSGPGDAEADDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEQEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVYYDISTAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS 7P6Q,7P6P,7P6O,7P6N,7JNT,9HFP,8GDS,4WOT,7JOV,5U7Q,2H9V,2F2U,8X92,8X8Z,8X8Y,8X8X,6ED6 Rho-associated protein kinase 2 ROCK2_HUMAN O75116 Q53QZ0 Q53SJ7 Q9UQN5 1290518 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 Rho-associated protein kinase 1 Homo sapiens 36.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2734&target=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS 8ZH5,7JOU,5WNH,5WNG,5WNF,5WNE,5UZJ,5KKT,5KKS,5HVU,5BML,4YVE,4YVC,3V8S,3TWJ,3TV7,3NDM,3NCZ,3D9V,2ETR,2ETK,2ESM,6E9W,4W7P,2V55,7S26,7S25,8X92,8X8Z,8X8Y,8X8X,6ED6,3O0Z,8P0S Rho-associated protein kinase 1 ROCK1_HUMAN Q13464 B0YJ91 Q2KHM4 Q59GZ4 1290519 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens 117 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1592&target=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF 3MVJ,7Y1G,6QJ7,6C0U,5UZK,5J5X,5IZJ,5IZF,5BX7,5BX6,4UJB,4UJA,4UJ9,4UJ2,4UJ1,3VQH,3POO,3P0M,3OXT,3OWP,3OVV,3OOG,3L9L,3AGM,3AGL,9DCD,6NO7,6BYS,4WB5,4DG3,4DFY,2GNI,2GNH,2GNG,2GNF,1XH9,9O7V,9EDE,9EDD,9EDC,7V0G,7UJX,5JR7,4X6Q,4WBB,4HPU,4HPT,4DIN,4DH8,4DH7,4DH5,4DH3,4DH1,4DG2,4DG0,3TNQ,3TNP,3OW3,3O7L,3IDC,3IDB,3FJQ,2QVS,2QCS,2CPK,1REK,1REJ,1RE8,1L3R,1JLU,1J3H,1FMO,1BX6,1BKX,1ATP,6E21,4XW6,4XW5,4XW4,4IB3,4IB1,4IB0,4IAZ,4IAY,4IAK,4IAI,4IAF,4IAD,4IAC,2UZW,2UZV,2UZU,2UZT,5X3F cAMP-dependent protein kinase catalytic subunit alpha KAPCA_HUMAN P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9 1290520 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 Tyrosine-protein kinase JAK1 Homo sapiens 50000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4917&target=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 5L04,5IXI,5IXD,6SMB,6SM8,6ELR,8S85,6RSH,6RSE,6RSD,6RSC,6RSB,6N7D,6N7C,6N7B,6N7A,6N79,6N78,6N77,6HZU,5WO4,5HX8,4K77,4K6Z,4IVD,4IVC,4IVB,4I5C,4FK6,4EI4,4EHZ,4E5W,4E4N,4E4L,6GGH,6TPF,6TPE,6AAH,5E1E,3EYH,3EYG Tyrosine-protein kinase JAK1 JAK1_HUMAN P23458 Q59GQ2 Q9UD26 1290521 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 Tyrosine-protein kinase JAK2 Homo sapiens 36241 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4918&target=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 6E2Q,6E2P,4JIA,4JI9,4IVA,4HGE,6WTQ,6WTP,6WTO,6WTN,4AQC,5AEP,4D1S,4D0X,4D0W,3RVG,3TJD,3TJC,7REE,7LL4,5CF6,5CF5,5CF4,4ZIM,5CF8,3Q32,3LPB,3KRR,7LL5,6VSN,6VS3,6VNM,6VNL,6VNK,6VNJ,6VNI,6VNH,6VNG,6VNF,6VNE,6VNC,6VNB,6VN8,6VGL,6DRW,5USY,3E64,3E63,3E62,4P7E,3FUP,2B7A,3KCK,3IOK,3IO7,4YTI,4YTH,4YTF,4YTC,7UYW,3JY9,7F7W Tyrosine-protein kinase JAK2 JAK2_HUMAN O60674 O14636 O75297 1290522 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 Tyrosine-protein kinase JAK3 Homo sapiens 43246 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4919&target=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRIRFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFAQHRSDLVSGRLPVGLSLKEQGECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVRRALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGDGGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPGLPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTGGSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRPHSSLRELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQYQLSQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCMESFLEAASLMSQVSYRHLVLLHGVCMAGDSTMVQEFVHLGAIDMYLRKRGHLVPASWKLQVVKQLAYALNYLEDKGLPHGNVSARKVLLAREGADGSPPFIKLSDPGVSPAVLSLEMLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYEDRQQLPAPKWTELALLIQQCMAYEPVQRPSFRAVIRDLNSLISSDYELLSDPTPGALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 7C3N,3PJC,6DUD,6DB4,6DB3,6DA4,5TTV,5TTU,5TTS,5TOZ Tyrosine-protein kinase JAK3 JAK3_HUMAN P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2 N/A A0A024R7M7 1290523 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 Non-receptor tyrosine-protein kinase TYK2 Homo sapiens 50000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4916&target=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC 4PO6,3ZON,5C03,5C01,8TB6,8TB5,3NZ0,7UYU,7UYT,7UYS,7UYR,8S9A,8S99,8S98,7AX4 Non-receptor tyrosine-protein kinase TYK2 TYK2_HUMAN P29597 Q6QB10 Q96CH0 1290524 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 Inhibitor of nuclear factor kappa-B kinase subunit beta Homo sapiens 50000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2933&target=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS Inhibitor of nuclear factor kappa-B kinase subunit beta IKKB_HUMAN O14920 B4DZ30 B4E0U4 O75327 1290525 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 Rho-associated protein kinase 2 Homo sapiens 14.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5478&target=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MSRPPPTGKMPGAPETAPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRENLLLSDSPSCRETDSIQSRKNEESQEIQKKLYTLEEHLSNEMQAKEELEQKCKSVNTRLEKTAKELEEEITLRKSVESALRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQNSQISTEKVNQLQRQLDETNALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRICGLEEDLKNGKILLAKVELEKRQLQERFTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKATKARLADKNKIYESIEEAKSEAMKEMEKKLLEERTLKQKVENLLLEAEKRCSLLDCDLKQSQQKINELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLGKELQQKKQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDVQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGNDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGLDSSSIGSGPGDAEADDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEQEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVYYDISTAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS 7P6Q,7P6P,7P6O,7P6N,7JNT,9HFP,8GDS,4WOT,7JOV,5U7Q,2H9V,2F2U,8X92,8X8Z,8X8Y,8X8X,6ED6 Rho-associated protein kinase 2 ROCK2_HUMAN O75116 Q53QZ0 Q53SJ7 Q9UQN5 1290526 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 Rho-associated protein kinase 1 Homo sapiens 21.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2734&target=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS 8ZH5,7JOU,5WNH,5WNG,5WNF,5WNE,5UZJ,5KKT,5KKS,5HVU,5BML,4YVE,4YVC,3V8S,3TWJ,3TV7,3NDM,3NCZ,3D9V,2ETR,2ETK,2ESM,6E9W,4W7P,2V55,7S26,7S25,8X92,8X8Z,8X8Y,8X8X,6ED6,3O0Z,8P0S Rho-associated protein kinase 1 ROCK1_HUMAN Q13464 B0YJ91 Q2KHM4 Q59GZ4 1290527 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens 81.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1592&target=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF 3MVJ,7Y1G,6QJ7,6C0U,5UZK,5J5X,5IZJ,5IZF,5BX7,5BX6,4UJB,4UJA,4UJ9,4UJ2,4UJ1,3VQH,3POO,3P0M,3OXT,3OWP,3OVV,3OOG,3L9L,3AGM,3AGL,9DCD,6NO7,6BYS,4WB5,4DG3,4DFY,2GNI,2GNH,2GNG,2GNF,1XH9,9O7V,9EDE,9EDD,9EDC,7V0G,7UJX,5JR7,4X6Q,4WBB,4HPU,4HPT,4DIN,4DH8,4DH7,4DH5,4DH3,4DH1,4DG2,4DG0,3TNQ,3TNP,3OW3,3O7L,3IDC,3IDB,3FJQ,2QVS,2QCS,2CPK,1REK,1REJ,1RE8,1L3R,1JLU,1J3H,1FMO,1BX6,1BKX,1ATP,6E21,4XW6,4XW5,4XW4,4IB3,4IB1,4IB0,4IAZ,4IAY,4IAK,4IAI,4IAF,4IAD,4IAC,2UZW,2UZV,2UZU,2UZT,5X3F cAMP-dependent protein kinase catalytic subunit alpha KAPCA_HUMAN P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9 1290528 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 Tyrosine-protein kinase JAK1 Homo sapiens 50000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4917&target=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 5L04,5IXI,5IXD,6SMB,6SM8,6ELR,8S85,6RSH,6RSE,6RSD,6RSC,6RSB,6N7D,6N7C,6N7B,6N7A,6N79,6N78,6N77,6HZU,5WO4,5HX8,4K77,4K6Z,4IVD,4IVC,4IVB,4I5C,4FK6,4EI4,4EHZ,4E5W,4E4N,4E4L,6GGH,6TPF,6TPE,6AAH,5E1E,3EYH,3EYG Tyrosine-protein kinase JAK1 JAK1_HUMAN P23458 Q59GQ2 Q9UD26 1290529 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 Tyrosine-protein kinase JAK2 Homo sapiens 42354 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4918&target=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 6E2Q,6E2P,4JIA,4JI9,4IVA,4HGE,6WTQ,6WTP,6WTO,6WTN,4AQC,5AEP,4D1S,4D0X,4D0W,3RVG,3TJD,3TJC,7REE,7LL4,5CF6,5CF5,5CF4,4ZIM,5CF8,3Q32,3LPB,3KRR,7LL5,6VSN,6VS3,6VNM,6VNL,6VNK,6VNJ,6VNI,6VNH,6VNG,6VNF,6VNE,6VNC,6VNB,6VN8,6VGL,6DRW,5USY,3E64,3E63,3E62,4P7E,3FUP,2B7A,3KCK,3IOK,3IO7,4YTI,4YTH,4YTF,4YTC,7UYW,3JY9,7F7W Tyrosine-protein kinase JAK2 JAK2_HUMAN O60674 O14636 O75297 1290530 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 Tyrosine-protein kinase JAK3 Homo sapiens 30082 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4919&target=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRIRFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFAQHRSDLVSGRLPVGLSLKEQGECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVRRALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGDGGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPGLPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTGGSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRPHSSLRELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQYQLSQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCMESFLEAASLMSQVSYRHLVLLHGVCMAGDSTMVQEFVHLGAIDMYLRKRGHLVPASWKLQVVKQLAYALNYLEDKGLPHGNVSARKVLLAREGADGSPPFIKLSDPGVSPAVLSLEMLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYEDRQQLPAPKWTELALLIQQCMAYEPVQRPSFRAVIRDLNSLISSDYELLSDPTPGALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 7C3N,3PJC,6DUD,6DB4,6DB3,6DA4,5TTV,5TTU,5TTS,5TOZ Tyrosine-protein kinase JAK3 JAK3_HUMAN P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2 N/A A0A024R7M7 1290531 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 Non-receptor tyrosine-protein kinase TYK2 Homo sapiens 50000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4916&target=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC 4PO6,3ZON,5C03,5C01,8TB6,8TB5,3NZ0,7UYU,7UYT,7UYS,7UYR,8S9A,8S99,8S98,7AX4 Non-receptor tyrosine-protein kinase TYK2 TYK2_HUMAN P29597 Q6QB10 Q96CH0 1290532 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 Inhibitor of nuclear factor kappa-B kinase subunit beta Homo sapiens 40091 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2933&target=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS Inhibitor of nuclear factor kappa-B kinase subunit beta IKKB_HUMAN O14920 B4DZ30 B4E0U4 O75327 1290533 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 Rho-associated protein kinase 2 Homo sapiens 13.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5478&target=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MSRPPPTGKMPGAPETAPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRENLLLSDSPSCRETDSIQSRKNEESQEIQKKLYTLEEHLSNEMQAKEELEQKCKSVNTRLEKTAKELEEEITLRKSVESALRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQNSQISTEKVNQLQRQLDETNALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRICGLEEDLKNGKILLAKVELEKRQLQERFTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKATKARLADKNKIYESIEEAKSEAMKEMEKKLLEERTLKQKVENLLLEAEKRCSLLDCDLKQSQQKINELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLGKELQQKKQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDVQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGNDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGLDSSSIGSGPGDAEADDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEQEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVYYDISTAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS 7P6Q,7P6P,7P6O,7P6N,7JNT,9HFP,8GDS,4WOT,7JOV,5U7Q,2H9V,2F2U,8X92,8X8Z,8X8Y,8X8X,6ED6 Rho-associated protein kinase 2 ROCK2_HUMAN O75116 Q53QZ0 Q53SJ7 Q9UQN5 1290534 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 Rho-associated protein kinase 1 Homo sapiens 29.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2734&target=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS 8ZH5,7JOU,5WNH,5WNG,5WNF,5WNE,5UZJ,5KKT,5KKS,5HVU,5BML,4YVE,4YVC,3V8S,3TWJ,3TV7,3NDM,3NCZ,3D9V,2ETR,2ETK,2ESM,6E9W,4W7P,2V55,7S26,7S25,8X92,8X8Z,8X8Y,8X8X,6ED6,3O0Z,8P0S Rho-associated protein kinase 1 ROCK1_HUMAN Q13464 B0YJ91 Q2KHM4 Q59GZ4 1290535 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens 317 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1592&target=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF 3MVJ,7Y1G,6QJ7,6C0U,5UZK,5J5X,5IZJ,5IZF,5BX7,5BX6,4UJB,4UJA,4UJ9,4UJ2,4UJ1,3VQH,3POO,3P0M,3OXT,3OWP,3OVV,3OOG,3L9L,3AGM,3AGL,9DCD,6NO7,6BYS,4WB5,4DG3,4DFY,2GNI,2GNH,2GNG,2GNF,1XH9,9O7V,9EDE,9EDD,9EDC,7V0G,7UJX,5JR7,4X6Q,4WBB,4HPU,4HPT,4DIN,4DH8,4DH7,4DH5,4DH3,4DH1,4DG2,4DG0,3TNQ,3TNP,3OW3,3O7L,3IDC,3IDB,3FJQ,2QVS,2QCS,2CPK,1REK,1REJ,1RE8,1L3R,1JLU,1J3H,1FMO,1BX6,1BKX,1ATP,6E21,4XW6,4XW5,4XW4,4IB3,4IB1,4IB0,4IAZ,4IAY,4IAK,4IAI,4IAF,4IAD,4IAC,2UZW,2UZV,2UZU,2UZT,5X3F cAMP-dependent protein kinase catalytic subunit alpha KAPCA_HUMAN P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9 1290536 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 Tyrosine-protein kinase JAK1 Homo sapiens 50000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4917&target=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 5L04,5IXI,5IXD,6SMB,6SM8,6ELR,8S85,6RSH,6RSE,6RSD,6RSC,6RSB,6N7D,6N7C,6N7B,6N7A,6N79,6N78,6N77,6HZU,5WO4,5HX8,4K77,4K6Z,4IVD,4IVC,4IVB,4I5C,4FK6,4EI4,4EHZ,4E5W,4E4N,4E4L,6GGH,6TPF,6TPE,6AAH,5E1E,3EYH,3EYG Tyrosine-protein kinase JAK1 JAK1_HUMAN P23458 Q59GQ2 Q9UD26 1290537 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 Tyrosine-protein kinase JAK2 Homo sapiens 41673 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4918&target=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 6E2Q,6E2P,4JIA,4JI9,4IVA,4HGE,6WTQ,6WTP,6WTO,6WTN,4AQC,5AEP,4D1S,4D0X,4D0W,3RVG,3TJD,3TJC,7REE,7LL4,5CF6,5CF5,5CF4,4ZIM,5CF8,3Q32,3LPB,3KRR,7LL5,6VSN,6VS3,6VNM,6VNL,6VNK,6VNJ,6VNI,6VNH,6VNG,6VNF,6VNE,6VNC,6VNB,6VN8,6VGL,6DRW,5USY,3E64,3E63,3E62,4P7E,3FUP,2B7A,3KCK,3IOK,3IO7,4YTI,4YTH,4YTF,4YTC,7UYW,3JY9,7F7W Tyrosine-protein kinase JAK2 JAK2_HUMAN O60674 O14636 O75297 1290538 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 Tyrosine-protein kinase JAK3 Homo sapiens 11632 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4919&target=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRIRFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFAQHRSDLVSGRLPVGLSLKEQGECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVRRALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGDGGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPGLPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTGGSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRPHSSLRELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQYQLSQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCMESFLEAASLMSQVSYRHLVLLHGVCMAGDSTMVQEFVHLGAIDMYLRKRGHLVPASWKLQVVKQLAYALNYLEDKGLPHGNVSARKVLLAREGADGSPPFIKLSDPGVSPAVLSLEMLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYEDRQQLPAPKWTELALLIQQCMAYEPVQRPSFRAVIRDLNSLISSDYELLSDPTPGALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 7C3N,3PJC,6DUD,6DB4,6DB3,6DA4,5TTV,5TTU,5TTS,5TOZ Tyrosine-protein kinase JAK3 JAK3_HUMAN P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2 N/A A0A024R7M7 1290539 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 Non-receptor tyrosine-protein kinase TYK2 Homo sapiens 50000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4916&target=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC 4PO6,3ZON,5C03,5C01,8TB6,8TB5,3NZ0,7UYU,7UYT,7UYS,7UYR,8S9A,8S99,8S98,7AX4 Non-receptor tyrosine-protein kinase TYK2 TYK2_HUMAN P29597 Q6QB10 Q96CH0 1290540 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 Inhibitor of nuclear factor kappa-B kinase subunit beta Homo sapiens 46807 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2933&target=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS Inhibitor of nuclear factor kappa-B kinase subunit beta IKKB_HUMAN O14920 B4DZ30 B4E0U4 O75327 1290541 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:13,t:9| InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52) HSRYETVWRVWJQQ-UHFFFAOYSA-N 511486 US11059789, Example 19::US11691950, Example 19 Rho-associated protein kinase 2 Homo sapiens 27.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5478&target=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MSRPPPTGKMPGAPETAPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRENLLLSDSPSCRETDSIQSRKNEESQEIQKKLYTLEEHLSNEMQAKEELEQKCKSVNTRLEKTAKELEEEITLRKSVESALRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQNSQISTEKVNQLQRQLDETNALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRICGLEEDLKNGKILLAKVELEKRQLQERFTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKATKARLADKNKIYESIEEAKSEAMKEMEKKLLEERTLKQKVENLLLEAEKRCSLLDCDLKQSQQKINELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLGKELQQKKQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDVQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGNDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGLDSSSIGSGPGDAEADDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEQEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVYYDISTAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS 7P6Q,7P6P,7P6O,7P6N,7JNT,9HFP,8GDS,4WOT,7JOV,5U7Q,2H9V,2F2U,8X92,8X8Z,8X8Y,8X8X,6ED6 Rho-associated protein kinase 2 ROCK2_HUMAN O75116 Q53QZ0 Q53SJ7 Q9UQN5 1290542 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:13,t:9| InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52) HSRYETVWRVWJQQ-UHFFFAOYSA-N 511486 US11059789, Example 19::US11691950, Example 19 Rho-associated protein kinase 1 Homo sapiens 58.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2734&target=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS 8ZH5,7JOU,5WNH,5WNG,5WNF,5WNE,5UZJ,5KKT,5KKS,5HVU,5BML,4YVE,4YVC,3V8S,3TWJ,3TV7,3NDM,3NCZ,3D9V,2ETR,2ETK,2ESM,6E9W,4W7P,2V55,7S26,7S25,8X92,8X8Z,8X8Y,8X8X,6ED6,3O0Z,8P0S Rho-associated protein kinase 1 ROCK1_HUMAN Q13464 B0YJ91 Q2KHM4 Q59GZ4 1290543 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:13,t:9| InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52) HSRYETVWRVWJQQ-UHFFFAOYSA-N 511486 US11059789, Example 19::US11691950, Example 19 cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens 332 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1592&target=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF 3MVJ,7Y1G,6QJ7,6C0U,5UZK,5J5X,5IZJ,5IZF,5BX7,5BX6,4UJB,4UJA,4UJ9,4UJ2,4UJ1,3VQH,3POO,3P0M,3OXT,3OWP,3OVV,3OOG,3L9L,3AGM,3AGL,9DCD,6NO7,6BYS,4WB5,4DG3,4DFY,2GNI,2GNH,2GNG,2GNF,1XH9,9O7V,9EDE,9EDD,9EDC,7V0G,7UJX,5JR7,4X6Q,4WBB,4HPU,4HPT,4DIN,4DH8,4DH7,4DH5,4DH3,4DH1,4DG2,4DG0,3TNQ,3TNP,3OW3,3O7L,3IDC,3IDB,3FJQ,2QVS,2QCS,2CPK,1REK,1REJ,1RE8,1L3R,1JLU,1J3H,1FMO,1BX6,1BKX,1ATP,6E21,4XW6,4XW5,4XW4,4IB3,4IB1,4IB0,4IAZ,4IAY,4IAK,4IAI,4IAF,4IAD,4IAC,2UZW,2UZV,2UZU,2UZT,5X3F cAMP-dependent protein kinase catalytic subunit alpha KAPCA_HUMAN P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9 1290544 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:13,t:9| InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52) HSRYETVWRVWJQQ-UHFFFAOYSA-N 511486 US11059789, Example 19::US11691950, Example 19 Tyrosine-protein kinase JAK1 Homo sapiens 9574 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4917&target=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 5L04,5IXI,5IXD,6SMB,6SM8,6ELR,8S85,6RSH,6RSE,6RSD,6RSC,6RSB,6N7D,6N7C,6N7B,6N7A,6N79,6N78,6N77,6HZU,5WO4,5HX8,4K77,4K6Z,4IVD,4IVC,4IVB,4I5C,4FK6,4EI4,4EHZ,4E5W,4E4N,4E4L,6GGH,6TPF,6TPE,6AAH,5E1E,3EYH,3EYG Tyrosine-protein kinase JAK1 JAK1_HUMAN P23458 Q59GQ2 Q9UD26 1290545 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:13,t:9| InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52) HSRYETVWRVWJQQ-UHFFFAOYSA-N 511486 US11059789, Example 19::US11691950, Example 19 Tyrosine-protein kinase JAK2 Homo sapiens 13799 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4918&target=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 6E2Q,6E2P,4JIA,4JI9,4IVA,4HGE,6WTQ,6WTP,6WTO,6WTN,4AQC,5AEP,4D1S,4D0X,4D0W,3RVG,3TJD,3TJC,7REE,7LL4,5CF6,5CF5,5CF4,4ZIM,5CF8,3Q32,3LPB,3KRR,7LL5,6VSN,6VS3,6VNM,6VNL,6VNK,6VNJ,6VNI,6VNH,6VNG,6VNF,6VNE,6VNC,6VNB,6VN8,6VGL,6DRW,5USY,3E64,3E63,3E62,4P7E,3FUP,2B7A,3KCK,3IOK,3IO7,4YTI,4YTH,4YTF,4YTC,7UYW,3JY9,7F7W Tyrosine-protein kinase JAK2 JAK2_HUMAN O60674 O14636 O75297 1290546 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:13,t:9| InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52) HSRYETVWRVWJQQ-UHFFFAOYSA-N 511486 US11059789, Example 19::US11691950, Example 19 Tyrosine-protein kinase JAK3 Homo sapiens 2573 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4919&target=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRIRFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFAQHRSDLVSGRLPVGLSLKEQGECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVRRALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGDGGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPGLPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTGGSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRPHSSLRELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQYQLSQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCMESFLEAASLMSQVSYRHLVLLHGVCMAGDSTMVQEFVHLGAIDMYLRKRGHLVPASWKLQVVKQLAYALNYLEDKGLPHGNVSARKVLLAREGADGSPPFIKLSDPGVSPAVLSLEMLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYEDRQQLPAPKWTELALLIQQCMAYEPVQRPSFRAVIRDLNSLISSDYELLSDPTPGALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 7C3N,3PJC,6DUD,6DB4,6DB3,6DA4,5TTV,5TTU,5TTS,5TOZ Tyrosine-protein kinase JAK3 JAK3_HUMAN P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2 N/A A0A024R7M7 1290547 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:13,t:9| InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52) HSRYETVWRVWJQQ-UHFFFAOYSA-N 511486 US11059789, Example 19::US11691950, Example 19 Non-receptor tyrosine-protein kinase TYK2 Homo sapiens 50000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4916&target=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC 4PO6,3ZON,5C03,5C01,8TB6,8TB5,3NZ0,7UYU,7UYT,7UYS,7UYR,8S9A,8S99,8S98,7AX4 Non-receptor tyrosine-protein kinase TYK2 TYK2_HUMAN P29597 Q6QB10 Q96CH0 1290548 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:13,t:9| InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52) HSRYETVWRVWJQQ-UHFFFAOYSA-N 511486 US11059789, Example 19::US11691950, Example 19 Inhibitor of nuclear factor kappa-B kinase subunit beta Homo sapiens 50000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2933&target=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS Inhibitor of nuclear factor kappa-B kinase subunit beta IKKB_HUMAN O14920 B4DZ30 B4E0U4 O75327 1290549 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 Protein kinase C eta type Homo sapiens 190 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=605&target=Protein+kinase+C+eta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Protein+kinase+C+eta+type&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MSSGTMKFNGYLRVRIGEAVGLQPTRWSLRHSLFKKGHQLLDPYLTVSVDQVRVGQTSTKQKTNKPTYNEEFCANVTDGGHLELAVFHETPLGYDHFVANCTLQFQELLRTTGASDTFEGWVDLEPEGKVFVVITLTGSFTEATLQRDRIFKHFTRKRQRAMRRRVHQINGHKFMATYLRQPTYCSHCREFIWGVFGKQGYQCQVCTCVVHKRCHHLIVTACTCQNNINKVDSKIAEQRFGINIPHKFSIHNYKVPTFCDHCGSLLWGIMRQGLQCKICKMNVHIRCQANVAPNCGVNAVELAKTLAGMGLQPGNISPTSKLVSRSTLRRQGKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFSYVSPELQP 2FK9 Protein kinase C eta type KPCL_HUMAN P24723 B4DJN5 Q16246 Q8NE03 1290550 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 Protein kinase C delta type Homo sapiens 152 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=603&target=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED 1YRK Protein kinase C delta type KPCD_HUMAN Q05655 B0KZ81 B2R834 Q15144 Q86XJ6 1290551 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 Protein kinase C epsilon type Homo sapiens 244 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=604&target=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEAPKDNEERVFRERMRPRKRQGAVRRRVHQVNGHKFMATYLRQPTYCSHCRDFIWGVIGKQGYQCQVCTCVVHKRCHELIITKCAGLKKQETPDQVGSQRFSVNMPHKFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVCKMNVHRRCETNVAPNCGVDARGIAKVLADLGVTPDKITNSGQRRKKLIAGAESPQPASGSSPSEEDRSKSAPTSPCDQEIKELENNIRKALSFDNRGEEHRAASSPDGQLMSPGENGEVRQGQAKRLGLDEFNFIKVLGKGSFGKVMLAELKGKDEVYAVKVLKKDVILQDDDVDCTMTEKRILALARKHPYLTQLYCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTSALMFLHQHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPHKRLGCVASQNGEDAIKQHPFFKEIDWVLLEQKKIKPPFKPRIKTKRDVNNFDQDFTREEPVLTLVDEAIVKQINQEEFKGFSYFGEDLMP Protein kinase C epsilon type KPCE_HUMAN Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81 1290552 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 RAC-alpha serine/threonine-protein kinase Homo sapiens 523 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=513&target=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA 3O96,6NPZ,6BUU,1UNR,1UNQ,1H10,2UVM RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1290554 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 Transmembrane prolyl 4-hydroxylase Homo sapiens 11.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5581&target=Transmembrane+prolyl+4-hydroxylase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Transmembrane+prolyl+4-hydroxylase&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MAAAAVTGQRPETAAAEEASRPQWAPPDHCQAQAAAGLGDGEDAPVRPLCKPRGICSRAYFLVLMVFVHLYLGNVLALLLFVHYSNGDESSDPGPQHRAQGPGPEPTLGPLTRLEGIKVGHERKVQLVTDRDHFIRTLSLKPLLFEIPGFLTDEECRLIIHLAQMKGLQRSQILPTEEYEEAMSTMQVSQLDLFRLLDQNRDGHLQLREVLAQTRLGNGWWMTPESIQEMYAAIKADPDGDGVLSLQEFSNMDLRDFHKYMRSHKAESSELVRNSHHTWLYQGEGAHHIMRAIRQRVLRLTRLSPEIVELSEPLQVVRYGEGGHYHAHVDSGPVYPETICSHTKLVANESVPFETSCRYMTVLFYLNNVTGGGETVFPVADNRTYDEMSLIQDDVDLRDTRRHCDKGNLRVKPQQGTAVFWYNYLPDGQGWVGDVDDYSLHGGCLVTRGTKWIANNWINVDPSRARQALFQQEMARLAREGGTDSQPEWALDRAYRDARVEL Transmembrane prolyl 4-hydroxylase P4HTM_HUMAN Q9NXG6 Q6PAG6 Q8TCJ9 Q8WV55 Q96F22 Q9BW77 1290555 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 Thymocyte selection-associated high mobility group box protein TOX Homo sapiens 100000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1469&target=Thymocyte+selection-associated+high+mobility+group+box+protein+TOX&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Thymocyte+selection-associated+high+mobility+group+box+protein+TOX&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MDVRFYPPPAQPAAAPDAPCLGPSPCLDPYYCNKFDGENMYMSMTEPSQDYVPASQSYPGPSLESEDFNIPPITPPSLPDHSLVHLNEVESGYHSLCHPMNHNGLLPFHPQNMDLPEITVSNMLGQDGTLLSNSISVMPDIRNPEGTQYSSHPQMAAMRPRGQPADIRQQPGMMPHGQLTTINQSQLSAQLGLNMGGSNVPHNSPSPPGSKSATPSPSSSVHEDEGDDTSKINGGEKRPASDMGKKPKTPKKKKKKDPNEPQKPVSAYALFFRDTQAAIKGQNPNATFGEVSKIVASMWDGLGEEQKQVYKKKTEAAKKEYLKQLAAYRASLVSKSYSEPVDVKTSQPPQLINSKPSVFHGPSQAHSALYLSSHYHQQPGMNPHLTAMHPSLPRNIAPKPNNQMPVTVSIANMAVSPPPPLQISPPLHQHLNMQQHQPLTMQQPLGNQLPMQVQSALHSPTMQQGFTLQPDYQTIINPTSTAAQVVTQAMEYVRSGCRNPPPQPVDWNNDYCSSGGMQRDKALYLT Thymocyte selection-associated high mobility group box protein TOX TOX_HUMAN O94900 Q96AV5 1290556 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:15,t:11| InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58) QXQGSOMQKZFIRY-UHFFFAOYSA-N 511480 US11059789, Example 40::US11691950, Example 40 Nuclear factor NF-kappa-B p105 subunit Homo sapiens 28.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 2O61,8TQD,9BOR,1NFI,7RG5,7RG4 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1290557 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 Protein kinase C eta type Homo sapiens 173 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=605&target=Protein+kinase+C+eta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Protein+kinase+C+eta+type&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MSSGTMKFNGYLRVRIGEAVGLQPTRWSLRHSLFKKGHQLLDPYLTVSVDQVRVGQTSTKQKTNKPTYNEEFCANVTDGGHLELAVFHETPLGYDHFVANCTLQFQELLRTTGASDTFEGWVDLEPEGKVFVVITLTGSFTEATLQRDRIFKHFTRKRQRAMRRRVHQINGHKFMATYLRQPTYCSHCREFIWGVFGKQGYQCQVCTCVVHKRCHHLIVTACTCQNNINKVDSKIAEQRFGINIPHKFSIHNYKVPTFCDHCGSLLWGIMRQGLQCKICKMNVHIRCQANVAPNCGVNAVELAKTLAGMGLQPGNISPTSKLVSRSTLRRQGKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFSYVSPELQP 2FK9 Protein kinase C eta type KPCL_HUMAN P24723 B4DJN5 Q16246 Q8NE03 1290558 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 Protein kinase C delta type Homo sapiens 225 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=603&target=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED 1YRK Protein kinase C delta type KPCD_HUMAN Q05655 B0KZ81 B2R834 Q15144 Q86XJ6 1290559 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 Protein kinase C epsilon type Homo sapiens 1578 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=604&target=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEAPKDNEERVFRERMRPRKRQGAVRRRVHQVNGHKFMATYLRQPTYCSHCRDFIWGVIGKQGYQCQVCTCVVHKRCHELIITKCAGLKKQETPDQVGSQRFSVNMPHKFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVCKMNVHRRCETNVAPNCGVDARGIAKVLADLGVTPDKITNSGQRRKKLIAGAESPQPASGSSPSEEDRSKSAPTSPCDQEIKELENNIRKALSFDNRGEEHRAASSPDGQLMSPGENGEVRQGQAKRLGLDEFNFIKVLGKGSFGKVMLAELKGKDEVYAVKVLKKDVILQDDDVDCTMTEKRILALARKHPYLTQLYCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTSALMFLHQHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPHKRLGCVASQNGEDAIKQHPFFKEIDWVLLEQKKIKPPFKPRIKTKRDVNNFDQDFTREEPVLTLVDEAIVKQINQEEFKGFSYFGEDLMP Protein kinase C epsilon type KPCE_HUMAN Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81 1290560 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 RAC-alpha serine/threonine-protein kinase Homo sapiens 955 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=513&target=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA 3O96,6NPZ,6BUU,1UNR,1UNQ,1H10,2UVM RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1290562 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 Transmembrane prolyl 4-hydroxylase Homo sapiens 4.50 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5581&target=Transmembrane+prolyl+4-hydroxylase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Transmembrane+prolyl+4-hydroxylase&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MAAAAVTGQRPETAAAEEASRPQWAPPDHCQAQAAAGLGDGEDAPVRPLCKPRGICSRAYFLVLMVFVHLYLGNVLALLLFVHYSNGDESSDPGPQHRAQGPGPEPTLGPLTRLEGIKVGHERKVQLVTDRDHFIRTLSLKPLLFEIPGFLTDEECRLIIHLAQMKGLQRSQILPTEEYEEAMSTMQVSQLDLFRLLDQNRDGHLQLREVLAQTRLGNGWWMTPESIQEMYAAIKADPDGDGVLSLQEFSNMDLRDFHKYMRSHKAESSELVRNSHHTWLYQGEGAHHIMRAIRQRVLRLTRLSPEIVELSEPLQVVRYGEGGHYHAHVDSGPVYPETICSHTKLVANESVPFETSCRYMTVLFYLNNVTGGGETVFPVADNRTYDEMSLIQDDVDLRDTRRHCDKGNLRVKPQQGTAVFWYNYLPDGQGWVGDVDDYSLHGGCLVTRGTKWIANNWINVDPSRARQALFQQEMARLAREGGTDSQPEWALDRAYRDARVEL Transmembrane prolyl 4-hydroxylase P4HTM_HUMAN Q9NXG6 Q6PAG6 Q8TCJ9 Q8WV55 Q96F22 Q9BW77 1290563 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 Thymocyte selection-associated high mobility group box protein TOX Homo sapiens 100000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1469&target=Thymocyte+selection-associated+high+mobility+group+box+protein+TOX&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Thymocyte+selection-associated+high+mobility+group+box+protein+TOX&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MDVRFYPPPAQPAAAPDAPCLGPSPCLDPYYCNKFDGENMYMSMTEPSQDYVPASQSYPGPSLESEDFNIPPITPPSLPDHSLVHLNEVESGYHSLCHPMNHNGLLPFHPQNMDLPEITVSNMLGQDGTLLSNSISVMPDIRNPEGTQYSSHPQMAAMRPRGQPADIRQQPGMMPHGQLTTINQSQLSAQLGLNMGGSNVPHNSPSPPGSKSATPSPSSSVHEDEGDDTSKINGGEKRPASDMGKKPKTPKKKKKKDPNEPQKPVSAYALFFRDTQAAIKGQNPNATFGEVSKIVASMWDGLGEEQKQVYKKKTEAAKKEYLKQLAAYRASLVSKSYSEPVDVKTSQPPQLINSKPSVFHGPSQAHSALYLSSHYHQQPGMNPHLTAMHPSLPRNIAPKPNNQMPVTVSIANMAVSPPPPLQISPPLHQHLNMQQHQPLTMQQPLGNQLPMQVQSALHSPTMQQGFTLQPDYQTIINPTSTAAQVVTQAMEYVRSGCRNPPPQPVDWNNDYCSSGGMQRDKALYLT Thymocyte selection-associated high mobility group box protein TOX TOX_HUMAN O94900 Q96AV5 1290564 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55) LYJKMVFAIXOQLE-UHFFFAOYSA-N 511481 US11059789, Example 25::US11691950, Example 25 Nuclear factor NF-kappa-B p105 subunit Homo sapiens 39.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 2O61,8TQD,9BOR,1NFI,7RG5,7RG4 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1290565 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 Protein kinase C eta type Homo sapiens 51.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=605&target=Protein+kinase+C+eta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Protein+kinase+C+eta+type&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MSSGTMKFNGYLRVRIGEAVGLQPTRWSLRHSLFKKGHQLLDPYLTVSVDQVRVGQTSTKQKTNKPTYNEEFCANVTDGGHLELAVFHETPLGYDHFVANCTLQFQELLRTTGASDTFEGWVDLEPEGKVFVVITLTGSFTEATLQRDRIFKHFTRKRQRAMRRRVHQINGHKFMATYLRQPTYCSHCREFIWGVFGKQGYQCQVCTCVVHKRCHHLIVTACTCQNNINKVDSKIAEQRFGINIPHKFSIHNYKVPTFCDHCGSLLWGIMRQGLQCKICKMNVHIRCQANVAPNCGVNAVELAKTLAGMGLQPGNISPTSKLVSRSTLRRQGKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFSYVSPELQP 2FK9 Protein kinase C eta type KPCL_HUMAN P24723 B4DJN5 Q16246 Q8NE03 1290566 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 Protein kinase C delta type Homo sapiens 56.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=603&target=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED 1YRK Protein kinase C delta type KPCD_HUMAN Q05655 B0KZ81 B2R834 Q15144 Q86XJ6 1290567 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 Protein kinase C epsilon type Homo sapiens 154 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=604&target=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEAPKDNEERVFRERMRPRKRQGAVRRRVHQVNGHKFMATYLRQPTYCSHCRDFIWGVIGKQGYQCQVCTCVVHKRCHELIITKCAGLKKQETPDQVGSQRFSVNMPHKFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVCKMNVHRRCETNVAPNCGVDARGIAKVLADLGVTPDKITNSGQRRKKLIAGAESPQPASGSSPSEEDRSKSAPTSPCDQEIKELENNIRKALSFDNRGEEHRAASSPDGQLMSPGENGEVRQGQAKRLGLDEFNFIKVLGKGSFGKVMLAELKGKDEVYAVKVLKKDVILQDDDVDCTMTEKRILALARKHPYLTQLYCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTSALMFLHQHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPHKRLGCVASQNGEDAIKQHPFFKEIDWVLLEQKKIKPPFKPRIKTKRDVNNFDQDFTREEPVLTLVDEAIVKQINQEEFKGFSYFGEDLMP Protein kinase C epsilon type KPCE_HUMAN Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81 1290568 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 RAC-alpha serine/threonine-protein kinase Homo sapiens 95.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=513&target=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA 3O96,6NPZ,6BUU,1UNR,1UNQ,1H10,2UVM RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1290570 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 Transmembrane prolyl 4-hydroxylase Homo sapiens 25.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5581&target=Transmembrane+prolyl+4-hydroxylase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Transmembrane+prolyl+4-hydroxylase&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MAAAAVTGQRPETAAAEEASRPQWAPPDHCQAQAAAGLGDGEDAPVRPLCKPRGICSRAYFLVLMVFVHLYLGNVLALLLFVHYSNGDESSDPGPQHRAQGPGPEPTLGPLTRLEGIKVGHERKVQLVTDRDHFIRTLSLKPLLFEIPGFLTDEECRLIIHLAQMKGLQRSQILPTEEYEEAMSTMQVSQLDLFRLLDQNRDGHLQLREVLAQTRLGNGWWMTPESIQEMYAAIKADPDGDGVLSLQEFSNMDLRDFHKYMRSHKAESSELVRNSHHTWLYQGEGAHHIMRAIRQRVLRLTRLSPEIVELSEPLQVVRYGEGGHYHAHVDSGPVYPETICSHTKLVANESVPFETSCRYMTVLFYLNNVTGGGETVFPVADNRTYDEMSLIQDDVDLRDTRRHCDKGNLRVKPQQGTAVFWYNYLPDGQGWVGDVDDYSLHGGCLVTRGTKWIANNWINVDPSRARQALFQQEMARLAREGGTDSQPEWALDRAYRDARVEL Transmembrane prolyl 4-hydroxylase P4HTM_HUMAN Q9NXG6 Q6PAG6 Q8TCJ9 Q8WV55 Q96F22 Q9BW77 1290571 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 Thymocyte selection-associated high mobility group box protein TOX Homo sapiens 100000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1469&target=Thymocyte+selection-associated+high+mobility+group+box+protein+TOX&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Thymocyte+selection-associated+high+mobility+group+box+protein+TOX&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MDVRFYPPPAQPAAAPDAPCLGPSPCLDPYYCNKFDGENMYMSMTEPSQDYVPASQSYPGPSLESEDFNIPPITPPSLPDHSLVHLNEVESGYHSLCHPMNHNGLLPFHPQNMDLPEITVSNMLGQDGTLLSNSISVMPDIRNPEGTQYSSHPQMAAMRPRGQPADIRQQPGMMPHGQLTTINQSQLSAQLGLNMGGSNVPHNSPSPPGSKSATPSPSSSVHEDEGDDTSKINGGEKRPASDMGKKPKTPKKKKKKDPNEPQKPVSAYALFFRDTQAAIKGQNPNATFGEVSKIVASMWDGLGEEQKQVYKKKTEAAKKEYLKQLAAYRASLVSKSYSEPVDVKTSQPPQLINSKPSVFHGPSQAHSALYLSSHYHQQPGMNPHLTAMHPSLPRNIAPKPNNQMPVTVSIANMAVSPPPPLQISPPLHQHLNMQQHQPLTMQQPLGNQLPMQVQSALHSPTMQQGFTLQPDYQTIINPTSTAAQVVTQAMEYVRSGCRNPPPQPVDWNNDYCSSGGMQRDKALYLT Thymocyte selection-associated high mobility group box protein TOX TOX_HUMAN O94900 Q96AV5 1290572 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55) NKWSAYGUIMPROA-UHFFFAOYSA-N 511482 US11059789, Example 83::US11691950, Example 83 Nuclear factor NF-kappa-B p105 subunit Homo sapiens 55.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 2O61,8TQD,9BOR,1NFI,7RG5,7RG4 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1290573 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 Protein kinase C eta type Homo sapiens 282 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=605&target=Protein+kinase+C+eta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Protein+kinase+C+eta+type&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MSSGTMKFNGYLRVRIGEAVGLQPTRWSLRHSLFKKGHQLLDPYLTVSVDQVRVGQTSTKQKTNKPTYNEEFCANVTDGGHLELAVFHETPLGYDHFVANCTLQFQELLRTTGASDTFEGWVDLEPEGKVFVVITLTGSFTEATLQRDRIFKHFTRKRQRAMRRRVHQINGHKFMATYLRQPTYCSHCREFIWGVFGKQGYQCQVCTCVVHKRCHHLIVTACTCQNNINKVDSKIAEQRFGINIPHKFSIHNYKVPTFCDHCGSLLWGIMRQGLQCKICKMNVHIRCQANVAPNCGVNAVELAKTLAGMGLQPGNISPTSKLVSRSTLRRQGKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFSYVSPELQP 2FK9 Protein kinase C eta type KPCL_HUMAN P24723 B4DJN5 Q16246 Q8NE03 1290574 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 Protein kinase C delta type Homo sapiens 357 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=603&target=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED 1YRK Protein kinase C delta type KPCD_HUMAN Q05655 B0KZ81 B2R834 Q15144 Q86XJ6 1290575 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 Protein kinase C epsilon type Homo sapiens 3614 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=604&target=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEAPKDNEERVFRERMRPRKRQGAVRRRVHQVNGHKFMATYLRQPTYCSHCRDFIWGVIGKQGYQCQVCTCVVHKRCHELIITKCAGLKKQETPDQVGSQRFSVNMPHKFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVCKMNVHRRCETNVAPNCGVDARGIAKVLADLGVTPDKITNSGQRRKKLIAGAESPQPASGSSPSEEDRSKSAPTSPCDQEIKELENNIRKALSFDNRGEEHRAASSPDGQLMSPGENGEVRQGQAKRLGLDEFNFIKVLGKGSFGKVMLAELKGKDEVYAVKVLKKDVILQDDDVDCTMTEKRILALARKHPYLTQLYCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTSALMFLHQHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPHKRLGCVASQNGEDAIKQHPFFKEIDWVLLEQKKIKPPFKPRIKTKRDVNNFDQDFTREEPVLTLVDEAIVKQINQEEFKGFSYFGEDLMP Protein kinase C epsilon type KPCE_HUMAN Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81 1290576 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 RAC-alpha serine/threonine-protein kinase Homo sapiens 1358 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=513&target=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA 3O96,6NPZ,6BUU,1UNR,1UNQ,1H10,2UVM RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1290578 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 Transmembrane prolyl 4-hydroxylase Homo sapiens 15.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5581&target=Transmembrane+prolyl+4-hydroxylase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Transmembrane+prolyl+4-hydroxylase&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MAAAAVTGQRPETAAAEEASRPQWAPPDHCQAQAAAGLGDGEDAPVRPLCKPRGICSRAYFLVLMVFVHLYLGNVLALLLFVHYSNGDESSDPGPQHRAQGPGPEPTLGPLTRLEGIKVGHERKVQLVTDRDHFIRTLSLKPLLFEIPGFLTDEECRLIIHLAQMKGLQRSQILPTEEYEEAMSTMQVSQLDLFRLLDQNRDGHLQLREVLAQTRLGNGWWMTPESIQEMYAAIKADPDGDGVLSLQEFSNMDLRDFHKYMRSHKAESSELVRNSHHTWLYQGEGAHHIMRAIRQRVLRLTRLSPEIVELSEPLQVVRYGEGGHYHAHVDSGPVYPETICSHTKLVANESVPFETSCRYMTVLFYLNNVTGGGETVFPVADNRTYDEMSLIQDDVDLRDTRRHCDKGNLRVKPQQGTAVFWYNYLPDGQGWVGDVDDYSLHGGCLVTRGTKWIANNWINVDPSRARQALFQQEMARLAREGGTDSQPEWALDRAYRDARVEL Transmembrane prolyl 4-hydroxylase P4HTM_HUMAN Q9NXG6 Q6PAG6 Q8TCJ9 Q8WV55 Q96F22 Q9BW77 1290579 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 Thymocyte selection-associated high mobility group box protein TOX Homo sapiens 100000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1469&target=Thymocyte+selection-associated+high+mobility+group+box+protein+TOX&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Thymocyte+selection-associated+high+mobility+group+box+protein+TOX&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MDVRFYPPPAQPAAAPDAPCLGPSPCLDPYYCNKFDGENMYMSMTEPSQDYVPASQSYPGPSLESEDFNIPPITPPSLPDHSLVHLNEVESGYHSLCHPMNHNGLLPFHPQNMDLPEITVSNMLGQDGTLLSNSISVMPDIRNPEGTQYSSHPQMAAMRPRGQPADIRQQPGMMPHGQLTTINQSQLSAQLGLNMGGSNVPHNSPSPPGSKSATPSPSSSVHEDEGDDTSKINGGEKRPASDMGKKPKTPKKKKKKDPNEPQKPVSAYALFFRDTQAAIKGQNPNATFGEVSKIVASMWDGLGEEQKQVYKKKTEAAKKEYLKQLAAYRASLVSKSYSEPVDVKTSQPPQLINSKPSVFHGPSQAHSALYLSSHYHQQPGMNPHLTAMHPSLPRNIAPKPNNQMPVTVSIANMAVSPPPPLQISPPLHQHLNMQQHQPLTMQQPLGNQLPMQVQSALHSPTMQQGFTLQPDYQTIINPTSTAAQVVTQAMEYVRSGCRNPPPQPVDWNNDYCSSGGMQRDKALYLT Thymocyte selection-associated high mobility group box protein TOX TOX_HUMAN O94900 Q96AV5 1290580 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57) BJLOBSMGZUMYOP-UHFFFAOYSA-N 511483 US11059789, Example 66::US11691950, Example 66 Nuclear factor NF-kappa-B p105 subunit Homo sapiens 55.0 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 2O61,8TQD,9BOR,1NFI,7RG5,7RG4 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1290581 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 Protein kinase C eta type Homo sapiens 145 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=605&target=Protein+kinase+C+eta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Protein+kinase+C+eta+type&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MSSGTMKFNGYLRVRIGEAVGLQPTRWSLRHSLFKKGHQLLDPYLTVSVDQVRVGQTSTKQKTNKPTYNEEFCANVTDGGHLELAVFHETPLGYDHFVANCTLQFQELLRTTGASDTFEGWVDLEPEGKVFVVITLTGSFTEATLQRDRIFKHFTRKRQRAMRRRVHQINGHKFMATYLRQPTYCSHCREFIWGVFGKQGYQCQVCTCVVHKRCHHLIVTACTCQNNINKVDSKIAEQRFGINIPHKFSIHNYKVPTFCDHCGSLLWGIMRQGLQCKICKMNVHIRCQANVAPNCGVNAVELAKTLAGMGLQPGNISPTSKLVSRSTLRRQGKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFSYVSPELQP 2FK9 Protein kinase C eta type KPCL_HUMAN P24723 B4DJN5 Q16246 Q8NE03 1290582 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 Protein kinase C delta type Homo sapiens 142 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=603&target=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED 1YRK Protein kinase C delta type KPCD_HUMAN Q05655 B0KZ81 B2R834 Q15144 Q86XJ6 1290583 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 Protein kinase C epsilon type Homo sapiens 1575 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=604&target=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEAPKDNEERVFRERMRPRKRQGAVRRRVHQVNGHKFMATYLRQPTYCSHCRDFIWGVIGKQGYQCQVCTCVVHKRCHELIITKCAGLKKQETPDQVGSQRFSVNMPHKFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVCKMNVHRRCETNVAPNCGVDARGIAKVLADLGVTPDKITNSGQRRKKLIAGAESPQPASGSSPSEEDRSKSAPTSPCDQEIKELENNIRKALSFDNRGEEHRAASSPDGQLMSPGENGEVRQGQAKRLGLDEFNFIKVLGKGSFGKVMLAELKGKDEVYAVKVLKKDVILQDDDVDCTMTEKRILALARKHPYLTQLYCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTSALMFLHQHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPHKRLGCVASQNGEDAIKQHPFFKEIDWVLLEQKKIKPPFKPRIKTKRDVNNFDQDFTREEPVLTLVDEAIVKQINQEEFKGFSYFGEDLMP Protein kinase C epsilon type KPCE_HUMAN Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81 1290584 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 RAC-alpha serine/threonine-protein kinase Homo sapiens 1243 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=513&target=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA 3O96,6NPZ,6BUU,1UNR,1UNQ,1H10,2UVM RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1290586 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 Transmembrane prolyl 4-hydroxylase Homo sapiens 4.00 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5581&target=Transmembrane+prolyl+4-hydroxylase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Transmembrane+prolyl+4-hydroxylase&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MAAAAVTGQRPETAAAEEASRPQWAPPDHCQAQAAAGLGDGEDAPVRPLCKPRGICSRAYFLVLMVFVHLYLGNVLALLLFVHYSNGDESSDPGPQHRAQGPGPEPTLGPLTRLEGIKVGHERKVQLVTDRDHFIRTLSLKPLLFEIPGFLTDEECRLIIHLAQMKGLQRSQILPTEEYEEAMSTMQVSQLDLFRLLDQNRDGHLQLREVLAQTRLGNGWWMTPESIQEMYAAIKADPDGDGVLSLQEFSNMDLRDFHKYMRSHKAESSELVRNSHHTWLYQGEGAHHIMRAIRQRVLRLTRLSPEIVELSEPLQVVRYGEGGHYHAHVDSGPVYPETICSHTKLVANESVPFETSCRYMTVLFYLNNVTGGGETVFPVADNRTYDEMSLIQDDVDLRDTRRHCDKGNLRVKPQQGTAVFWYNYLPDGQGWVGDVDDYSLHGGCLVTRGTKWIANNWINVDPSRARQALFQQEMARLAREGGTDSQPEWALDRAYRDARVEL Transmembrane prolyl 4-hydroxylase P4HTM_HUMAN Q9NXG6 Q6PAG6 Q8TCJ9 Q8WV55 Q96F22 Q9BW77 1290587 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 Thymocyte selection-associated high mobility group box protein TOX Homo sapiens 55246 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1469&target=Thymocyte+selection-associated+high+mobility+group+box+protein+TOX&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Thymocyte+selection-associated+high+mobility+group+box+protein+TOX&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MDVRFYPPPAQPAAAPDAPCLGPSPCLDPYYCNKFDGENMYMSMTEPSQDYVPASQSYPGPSLESEDFNIPPITPPSLPDHSLVHLNEVESGYHSLCHPMNHNGLLPFHPQNMDLPEITVSNMLGQDGTLLSNSISVMPDIRNPEGTQYSSHPQMAAMRPRGQPADIRQQPGMMPHGQLTTINQSQLSAQLGLNMGGSNVPHNSPSPPGSKSATPSPSSSVHEDEGDDTSKINGGEKRPASDMGKKPKTPKKKKKKDPNEPQKPVSAYALFFRDTQAAIKGQNPNATFGEVSKIVASMWDGLGEEQKQVYKKKTEAAKKEYLKQLAAYRASLVSKSYSEPVDVKTSQPPQLINSKPSVFHGPSQAHSALYLSSHYHQQPGMNPHLTAMHPSLPRNIAPKPNNQMPVTVSIANMAVSPPPPLQISPPLHQHLNMQQHQPLTMQQPLGNQLPMQVQSALHSPTMQQGFTLQPDYQTIINPTSTAAQVVTQAMEYVRSGCRNPPPQPVDWNNDYCSSGGMQRDKALYLT Thymocyte selection-associated high mobility group box protein TOX TOX_HUMAN O94900 Q96AV5 1290588 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:14,t:10| InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57) SDZRYLPROGBZMB-UHFFFAOYSA-N 511484 US11059789, Example 33::US11691950, Example 33 Nuclear factor NF-kappa-B p105 subunit Homo sapiens 103 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 2O61,8TQD,9BOR,1NFI,7RG5,7RG4 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1290589 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 Protein kinase C eta type Homo sapiens 331 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=605&target=Protein+kinase+C+eta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Protein+kinase+C+eta+type&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MSSGTMKFNGYLRVRIGEAVGLQPTRWSLRHSLFKKGHQLLDPYLTVSVDQVRVGQTSTKQKTNKPTYNEEFCANVTDGGHLELAVFHETPLGYDHFVANCTLQFQELLRTTGASDTFEGWVDLEPEGKVFVVITLTGSFTEATLQRDRIFKHFTRKRQRAMRRRVHQINGHKFMATYLRQPTYCSHCREFIWGVFGKQGYQCQVCTCVVHKRCHHLIVTACTCQNNINKVDSKIAEQRFGINIPHKFSIHNYKVPTFCDHCGSLLWGIMRQGLQCKICKMNVHIRCQANVAPNCGVNAVELAKTLAGMGLQPGNISPTSKLVSRSTLRRQGKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFSYVSPELQP 2FK9 Protein kinase C eta type KPCL_HUMAN P24723 B4DJN5 Q16246 Q8NE03 1290590 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 Protein kinase C delta type Homo sapiens 509 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=603&target=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED 1YRK Protein kinase C delta type KPCD_HUMAN Q05655 B0KZ81 B2R834 Q15144 Q86XJ6 1290591 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 Protein kinase C epsilon type Homo sapiens 3455 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=604&target=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEAPKDNEERVFRERMRPRKRQGAVRRRVHQVNGHKFMATYLRQPTYCSHCRDFIWGVIGKQGYQCQVCTCVVHKRCHELIITKCAGLKKQETPDQVGSQRFSVNMPHKFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVCKMNVHRRCETNVAPNCGVDARGIAKVLADLGVTPDKITNSGQRRKKLIAGAESPQPASGSSPSEEDRSKSAPTSPCDQEIKELENNIRKALSFDNRGEEHRAASSPDGQLMSPGENGEVRQGQAKRLGLDEFNFIKVLGKGSFGKVMLAELKGKDEVYAVKVLKKDVILQDDDVDCTMTEKRILALARKHPYLTQLYCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTSALMFLHQHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPHKRLGCVASQNGEDAIKQHPFFKEIDWVLLEQKKIKPPFKPRIKTKRDVNNFDQDFTREEPVLTLVDEAIVKQINQEEFKGFSYFGEDLMP Protein kinase C epsilon type KPCE_HUMAN Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81 1290592 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 RAC-alpha serine/threonine-protein kinase Homo sapiens 2641 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=513&target=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA 3O96,6NPZ,6BUU,1UNR,1UNQ,1H10,2UVM RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1290594 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 Transmembrane prolyl 4-hydroxylase Homo sapiens 6.00 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5581&target=Transmembrane+prolyl+4-hydroxylase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Transmembrane+prolyl+4-hydroxylase&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MAAAAVTGQRPETAAAEEASRPQWAPPDHCQAQAAAGLGDGEDAPVRPLCKPRGICSRAYFLVLMVFVHLYLGNVLALLLFVHYSNGDESSDPGPQHRAQGPGPEPTLGPLTRLEGIKVGHERKVQLVTDRDHFIRTLSLKPLLFEIPGFLTDEECRLIIHLAQMKGLQRSQILPTEEYEEAMSTMQVSQLDLFRLLDQNRDGHLQLREVLAQTRLGNGWWMTPESIQEMYAAIKADPDGDGVLSLQEFSNMDLRDFHKYMRSHKAESSELVRNSHHTWLYQGEGAHHIMRAIRQRVLRLTRLSPEIVELSEPLQVVRYGEGGHYHAHVDSGPVYPETICSHTKLVANESVPFETSCRYMTVLFYLNNVTGGGETVFPVADNRTYDEMSLIQDDVDLRDTRRHCDKGNLRVKPQQGTAVFWYNYLPDGQGWVGDVDDYSLHGGCLVTRGTKWIANNWINVDPSRARQALFQQEMARLAREGGTDSQPEWALDRAYRDARVEL Transmembrane prolyl 4-hydroxylase P4HTM_HUMAN Q9NXG6 Q6PAG6 Q8TCJ9 Q8WV55 Q96F22 Q9BW77 1290595 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 Thymocyte selection-associated high mobility group box protein TOX Homo sapiens 100000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1469&target=Thymocyte+selection-associated+high+mobility+group+box+protein+TOX&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Thymocyte+selection-associated+high+mobility+group+box+protein+TOX&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MDVRFYPPPAQPAAAPDAPCLGPSPCLDPYYCNKFDGENMYMSMTEPSQDYVPASQSYPGPSLESEDFNIPPITPPSLPDHSLVHLNEVESGYHSLCHPMNHNGLLPFHPQNMDLPEITVSNMLGQDGTLLSNSISVMPDIRNPEGTQYSSHPQMAAMRPRGQPADIRQQPGMMPHGQLTTINQSQLSAQLGLNMGGSNVPHNSPSPPGSKSATPSPSSSVHEDEGDDTSKINGGEKRPASDMGKKPKTPKKKKKKDPNEPQKPVSAYALFFRDTQAAIKGQNPNATFGEVSKIVASMWDGLGEEQKQVYKKKTEAAKKEYLKQLAAYRASLVSKSYSEPVDVKTSQPPQLINSKPSVFHGPSQAHSALYLSSHYHQQPGMNPHLTAMHPSLPRNIAPKPNNQMPVTVSIANMAVSPPPPLQISPPLHQHLNMQQHQPLTMQQPLGNQLPMQVQSALHSPTMQQGFTLQPDYQTIINPTSTAAQVVTQAMEYVRSGCRNPPPQPVDWNNDYCSSGGMQRDKALYLT Thymocyte selection-associated high mobility group box protein TOX TOX_HUMAN O94900 Q96AV5 1290596 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:11,t:7| InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54) NZTPJNIILSLMRH-UHFFFAOYSA-N 511485 US11059789, Example 27::US11691950, Example 27 Nuclear factor NF-kappa-B p105 subunit Homo sapiens 1788 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 2O61,8TQD,9BOR,1NFI,7RG5,7RG4 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0 1290597 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:13,t:9| InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52) HSRYETVWRVWJQQ-UHFFFAOYSA-N 511486 US11059789, Example 19::US11691950, Example 19 Protein kinase C eta type Homo sapiens 436 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=605&target=Protein+kinase+C+eta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Protein+kinase+C+eta+type&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MSSGTMKFNGYLRVRIGEAVGLQPTRWSLRHSLFKKGHQLLDPYLTVSVDQVRVGQTSTKQKTNKPTYNEEFCANVTDGGHLELAVFHETPLGYDHFVANCTLQFQELLRTTGASDTFEGWVDLEPEGKVFVVITLTGSFTEATLQRDRIFKHFTRKRQRAMRRRVHQINGHKFMATYLRQPTYCSHCREFIWGVFGKQGYQCQVCTCVVHKRCHHLIVTACTCQNNINKVDSKIAEQRFGINIPHKFSIHNYKVPTFCDHCGSLLWGIMRQGLQCKICKMNVHIRCQANVAPNCGVNAVELAKTLAGMGLQPGNISPTSKLVSRSTLRRQGKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFSYVSPELQP 2FK9 Protein kinase C eta type KPCL_HUMAN P24723 B4DJN5 Q16246 Q8NE03 1290598 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:13,t:9| InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52) HSRYETVWRVWJQQ-UHFFFAOYSA-N 511486 US11059789, Example 19::US11691950, Example 19 Protein kinase C delta type Homo sapiens 589 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=603&target=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED 1YRK Protein kinase C delta type KPCD_HUMAN Q05655 B0KZ81 B2R834 Q15144 Q86XJ6 1290599 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:13,t:9| InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52) HSRYETVWRVWJQQ-UHFFFAOYSA-N 511486 US11059789, Example 19::US11691950, Example 19 Protein kinase C epsilon type Homo sapiens 4163 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=604&target=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEAPKDNEERVFRERMRPRKRQGAVRRRVHQVNGHKFMATYLRQPTYCSHCRDFIWGVIGKQGYQCQVCTCVVHKRCHELIITKCAGLKKQETPDQVGSQRFSVNMPHKFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVCKMNVHRRCETNVAPNCGVDARGIAKVLADLGVTPDKITNSGQRRKKLIAGAESPQPASGSSPSEEDRSKSAPTSPCDQEIKELENNIRKALSFDNRGEEHRAASSPDGQLMSPGENGEVRQGQAKRLGLDEFNFIKVLGKGSFGKVMLAELKGKDEVYAVKVLKKDVILQDDDVDCTMTEKRILALARKHPYLTQLYCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTSALMFLHQHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPHKRLGCVASQNGEDAIKQHPFFKEIDWVLLEQKKIKPPFKPRIKTKRDVNNFDQDFTREEPVLTLVDEAIVKQINQEEFKGFSYFGEDLMP Protein kinase C epsilon type KPCE_HUMAN Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81 1290600 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:13,t:9| InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52) HSRYETVWRVWJQQ-UHFFFAOYSA-N 511486 US11059789, Example 19::US11691950, Example 19 RAC-alpha serine/threonine-protein kinase Homo sapiens 2540 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=513&target=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA 3O96,6NPZ,6BUU,1UNR,1UNQ,1H10,2UVM RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1290602 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 |r,c:13,t:9| InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52) HSRYETVWRVWJQQ-UHFFFAOYSA-N 511486 US11059789, Example 19::US11691950, Example 19 Nuclear factor NF-kappa-B p105 subunit Homo sapiens 10000 US Patent 10.7270/Q2C82FD9 aid1919535 US11691950 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/4/2023 8/6/2023 Aerie Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8099&target=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Nuclear+factor+NF-kappa-B+p105+subunit&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI 2O61,8TQD,9BOR,1NFI,7RG5,7RG4 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0